114 related articles for article (PubMed ID: 27764039)
1. Increased 18F-2-Fluorodeoxysorbitol (18F-FDS) Activity in a Pituitary Spindle Cell Carcinoma.
Cheng X; Zhu W; Cui R
Clin Nucl Med; 2016 Dec; 41(12):953-955. PubMed ID: 27764039
[TBL] [Abstract][Full Text] [Related]
2. Validation of 2-
Li J; Zheng H; Fodah R; Warawa JM; Ng CK
J Nucl Med; 2018 Jan; 59(1):134-139. PubMed ID: 28848037
[TBL] [Abstract][Full Text] [Related]
3. Metastasis to the Sellar/Suprasellar Region in a Patient With Endometrial Carcinoma Detected by 18F-FDG PET/CT.
Salvatore B; D'Amico D; Fonti R
Clin Nucl Med; 2018 May; 43(5):363-364. PubMed ID: 29485436
[TBL] [Abstract][Full Text] [Related]
4. Role of
Kong Z; Wang Y; Ma W; Cheng X
BMC Endocr Disord; 2020 Jun; 20(1):84. PubMed ID: 32517690
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT in Urachal Abscess.
Flaus A; Longo MG; Dematons M; Granjon D; Prevot N
Clin Nucl Med; 2019 May; 44(5):e349-e350. PubMed ID: 30829865
[TBL] [Abstract][Full Text] [Related]
6. Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging Agent.
Wakabayashi H; Werner RA; Hayakawa N; Javadi MS; Xinyu C; Herrmann K; Rowe SP; Lapa C; Higuchi T
J Nucl Med; 2016 Oct; 57(10):1625-1628. PubMed ID: 27013700
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
8. All that glitters on PET is not cancer! 18F-deoxy-glucose avidity versus tumor biology: pituitary incidentaloma in a survivor of two previous unrelated malignancies.
Miljić D; Manojlović-Gačić E; Skender-Gazibara M; Milojević T; Bogosavljević V; Kozarević N; Petrović N; Stojanović M; Pekić S; Doknić M; Petakov M; Popović V
Endokrynol Pol; 2017; 68(3):352-359. PubMed ID: 28660992
[TBL] [Abstract][Full Text] [Related]
9. Is integrated 18F-FDG PET/MRI superior to 18F-FDG PET/CT in the differentiation of incidental tracer uptake in the head and neck area?
Schaarschmidt BM; Gomez B; Buchbender C; Grueneisen J; Nensa F; Sawicki LM; Ruhlmann V; Wetter A; Antoch G; Heusch P
Diagn Interv Radiol; 2017; 23(2):127-132. PubMed ID: 28089955
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic PET imaging in infections and inflammation using
Jørgensen NP; Alstrup AK; Mortensen FV; Knudsen K; Jakobsen S; Madsen LB; Bender D; Breining P; Petersen MS; Schleimann MH; Dagnæs-Hansen F; Gormsen LC; Borghammer P
Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):449-458. PubMed ID: 27785538
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
12. Imaging of tumor colonization by
Kang SR; Jo EJ; Nguyen VH; Zhang Y; Yoon HS; Pyo A; Kim DY; Hong Y; Bom HS; Min JJ
Theranostics; 2020; 10(11):4958-4966. PubMed ID: 32308761
[TBL] [Abstract][Full Text] [Related]
13. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
[TBL] [Abstract][Full Text] [Related]
14. Poorly Differentiated Primary Carcinoma of the Middle Ear on 18F-FDG PET/CT.
Nemer JS; Hsieh MP; Chen D; OʼToole KM; Yeh R
Clin Nucl Med; 2019 Jan; 44(1):e43-e45. PubMed ID: 30371599
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of 2-[
Braams LM; Sijbesma JWA; Boersma HH; van Dijl JM; Elsinga PH; Glaudemans AWJM; Slart RHJA; van Oosten M
Int J Med Microbiol; 2023 May; 313(3):151581. PubMed ID: 37209590
[TBL] [Abstract][Full Text] [Related]
16. Novel Functional Renal PET Imaging With 18F-FDS in Human Subjects.
Werner RA; Ordonez AA; Sanchez-Bautista J; Marcus C; Lapa C; Rowe SP; Pomper MG; Leal JP; Lodge MA; Javadi MS; Jain SK; Higuchi T
Clin Nucl Med; 2019 May; 44(5):410-411. PubMed ID: 30762825
[TBL] [Abstract][Full Text] [Related]
17. Utility of 11C-Methionine and 18F-FDG PET/CT in Patients With Functioning Pituitary Adenomas.
Feng Z; He D; Mao Z; Wang Z; Zhu Y; Zhang X; Wang H
Clin Nucl Med; 2016 Mar; 41(3):e130-4. PubMed ID: 26646998
[TBL] [Abstract][Full Text] [Related]
18. Improvement in diagnosis of metastatic pituitary carcinoma by 68Ga DOTATATE PET/CT.
Xiao J; Zhu Z; Zhong D; Ma W; Wang R
Clin Nucl Med; 2015 Feb; 40(2):e129-31. PubMed ID: 24873798
[TBL] [Abstract][Full Text] [Related]
19. Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography.
Weinstein EA; Ordonez AA; DeMarco VP; Murawski AM; Pokkali S; MacDonald EM; Klunk M; Mease RC; Pomper MG; Jain SK
Sci Transl Med; 2014 Oct; 6(259):259ra146. PubMed ID: 25338757
[TBL] [Abstract][Full Text] [Related]
20. MRI and FDG PET/CT Findings of Primary Orbit Leiomyosarcoma.
Zhou W; Hua F; Qian J; Bi Y; Guan Y
Clin Nucl Med; 2017 Jan; 42(1):e71-e74. PubMed ID: 27556798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
